237 related articles for article (PubMed ID: 30044319)
1. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
3. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
4. Metachronous bilateral testicular germ cell tumors: report of two cases.
James FV; Kumar A; Jayaprakash PG; Mathews A
J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
[TBL] [Abstract][Full Text] [Related]
5. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
Cullen M
Ann Oncol; 2012 Sep; 23 Suppl 10():x342-8. PubMed ID: 22987989
[TBL] [Abstract][Full Text] [Related]
6. [Late toxicity after chemotherapy of malignant testicular tumors].
Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
Urologe A; 1998 Nov; 37(6):635-47. PubMed ID: 9887493
[TBL] [Abstract][Full Text] [Related]
7. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
8. Management of Low-Stage Testicular Seminoma.
Pearce SM; Liauw SL; Eggener SE
Urol Clin North Am; 2015 Aug; 42(3):287-98. PubMed ID: 26216816
[TBL] [Abstract][Full Text] [Related]
9. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
Powles T; Robinson D; Shamash J; Moller H; Tranter N; Oliver T
Ann Oncol; 2008 Mar; 19(3):443-7. PubMed ID: 18048383
[TBL] [Abstract][Full Text] [Related]
10. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
[TBL] [Abstract][Full Text] [Related]
11. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
Ruf CG; Borck S; Anheuser P; Matthies C; Nestler T; Zecha H; Isbarn H; Dieckmann KP
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2335-2342. PubMed ID: 31286241
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy in stage I and stage II testicular cancer.
Albers P; Perabo FG; Melchior D; Siener R
World J Urol; 2001 Apr; 19(2):76-81. PubMed ID: 11374321
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.
Feldman DR; Voss MH; Jacobsen EP; Jia X; Suarez JA; Turkula S; Sheinfeld J; Bosl GJ; Motzer RJ; Patil S
Cancer; 2013 Jul; 119(14):2574-81. PubMed ID: 23606402
[TBL] [Abstract][Full Text] [Related]
15. Testicular germ-cell cancer.
Horwich A; Shipley J; Huddart R
Lancet; 2006 Mar; 367(9512):754-65. PubMed ID: 16517276
[TBL] [Abstract][Full Text] [Related]
16. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
17. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
18. Treatment of testicular intraepithelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: a survey of the German Testicular Cancer Study Group.
Dieckmann KP; Wilken S; Loy V; Matthies C; Kleinschmidt K; Bedke J; Martinschek A; Souchon R; Pichlmeier U; Kliesch S
Ann Oncol; 2013 May; 24(5):1332-7. PubMed ID: 23293116
[TBL] [Abstract][Full Text] [Related]
19. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
20. Minimizing toxicity in early-stage testicular cancer treatment.
Singhera M; Lees K; Huddart R; Horwich A
Expert Rev Anticancer Ther; 2012 Feb; 12(2):185-93. PubMed ID: 22316366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]